"Malignant pleural mesothelioma" trang 1 - tải miễn phí từ tailieunhanh
Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
12    44    1
Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients

Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
9    69    0
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: A cohort study

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: A cohort study
9    25    1
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
6    58    1
Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and longterm prognostic analysis

Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and longterm prognostic analysis
9    25    1
Biomarkers for predicting malignant pleural mesothelioma in a Mexican population

Biomarkers for predicting malignant pleural mesothelioma in a Mexican population
9    77    0
Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma

Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma
12    81    0
Physician requests by patients with malignant pleural mesothelioma in Japan

Physician requests by patients with malignant pleural mesothelioma in Japan
7    95    0
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
10    62    0
Quality of life of survivors of malignant pleural mesothelioma in Japan: A cross sectional study

Quality of life of survivors of malignant pleural mesothelioma in Japan: A cross sectional study
7    27    1
Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma
3    44    1
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol
8    51    1
Management of malignant pleural mesothelioma: A French multicenter retrospective study (GFPC 0802 study)

Management of malignant pleural mesothelioma: A French multicenter retrospective study (GFPC 0802 study)
6    25    1
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma

The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
6    47    1
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
13    80    1
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
13    36    1
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
13    45    1
TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages

TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages
10    69    1
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
7    53    1
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
24    33    1